Sunshine Biopharma Inc. Retained Earnings
Sunshine Biopharma Inc. (SBFM) had Retained Earnings of -$77.82 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$77.82M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$76.26M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$75.02M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$72.87M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$77.82M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$76.26M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | -$75.02M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$72.87M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$71.99M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | -$70.22M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | -$69.04M 10-K · filed 2026-04-03 | |
| 2024-09-30 | -$66.88M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | -$65.68M 10-Q/A · filed 2024-08-20 | |
| 2024-03-31 | -$65.19M 10-Q · filed 2024-05-20 | |
| 2023-12-31 | -$63.91M 10-K · filed 2025-04-01 | |
| 2023-09-30 | -$62.66M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$62.00M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$61.10M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | -$59.40M 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$35.89M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | -$34.43M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | -$33.89M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | -$32.66M 10-K · filed 2023-04-04 | |
| 2021-09-30 | -$33.32M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | -$29.28M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | -$26.40M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | -$20.22M 10-K · filed 2022-03-21 | |
| 2020-09-30 | -$19.13M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | -$18.44M 10-Q/A · filed 2020-08-31 | -$18.17M 10-Q · filed 2020-08-19 |
| 2020-03-31 | -$17.53M 10-Q · filed 2020-05-18 | |
| 2019-12-31 | -$17.43M 10-K · filed 2021-03-30 | |
| 2019-09-30 | -$17.04M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | -$16.69M 10-Q · filed 2019-08-15 | |
| 2019-03-31 | -$15.98M 10-Q · filed 2019-05-20 | |
| 2018-12-31 | -$15.77M 10-K · filed 2020-05-01 | |
| 2018-09-30 | -$15.44M 10-Q · filed 2018-11-16 | |
| 2018-06-30 | -$14.53M 10-Q · filed 2018-08-17 | |
| 2018-03-31 | -$13.88M 10-Q · filed 2018-05-22 | |
| 2017-12-31 | -$13.62M 10-K · filed 2019-04-12 | |
| 2017-09-30 | -$13.41M 10-Q · filed 2017-11-15 | |
| 2017-06-30 | -$13.26M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | -$12.77M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | -$12.58M 10-K · filed 2018-04-02 | |
| 2016-09-30 | -$11.45M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$9.78M 10-Q · filed 2016-08-16 | |
| 2016-03-31 | -$9.39M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | -$9.08M 10-K · filed 2017-04-17 | |
| 2015-09-30 | -$8.43M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | -$8.24M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | -$7.72M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | -$7.43M 10-K · filed 2016-03-25 | |
| 2014-09-30 | -$7.09M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | -$6.81M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | -$6.00M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | -$5.49M 10-K · filed 2015-03-11 | |
| 2013-09-30 | -$4.81M 10-Q · filed 2013-11-04 | |
| 2013-06-30 | -$4.63M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | -$4.48M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | -$3.00M 10-K · filed 2014-03-19 | |
| 2012-09-30 | -$2.81M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | -$2.44M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | -$2.33M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | -$2.29M 10-K · filed 2013-03-15 | |
| 2011-09-30 | -$1.92M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | -$1.80M 10-Q · filed 2011-08-09 | |
| 2011-03-31 | -$1.79M 10-Q · filed 2011-05-12 | |
| 2010-12-31 | -$1.74M 10-K · filed 2012-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |